A citation-based method for searching scientific literature

Niki M Medendorp, Marij A Hillen, Laxsini Murugesu, Cora M Aalfs, Anne M Stiggelbout, Ellen M A Smets. J Community Genet 2019
Times Cited: 12







List of co-cited articles
61 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.
Ilana Solomon, Elizabeth Harrington, Gillian Hooker, Lori Erby, Jennifer Axilbund, Heather Hampel, Kara Semotiuk, Amie Blanco, William M P Klein, Francis Giardiello,[...]. J Genet Couns 2017
30
58

A taxonomy of medical uncertainties in clinical genome sequencing.
Paul K J Han, Kendall L Umstead, Barbara A Bernhardt, Robert C Green, Steven Joffe, Barbara Koenig, Ian Krantz, Leo B Waterston, Leslie G Biesecker, Barbara B Biesecker. Genet Med 2017
53
41

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
41

Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility.
Angela R Bradbury, Linda Patrick-Miller, Jessica Long, Jacquelyn Powers, Jill Stopfer, Andrea Forman, Christina Rybak, Kristin Mattie, Amanda Brandt, Rachelle Chambers,[...]. Genet Med 2015
55
33

'We don't know for sure': discussion of uncertainty concerning multigene panel testing during initial cancer genetic consultations.
Niki M Medendorp, Marij A Hillen, Pomme E A van Maarschalkerweerd, Cora M Aalfs, Margreet G E M Ausems, Senno Verhoef, Lizet E van der Kolk, Lieke P V Berger, Marijke R Wevers, Anja Wagner,[...]. Fam Cancer 2020
7
57

Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Heidi S Lumish, Hallie Steinfeld, Carrie Koval, Donna Russo, Elana Levinson, Julia Wynn, James Duong, Wendy K Chung. J Genet Couns 2017
61
33

Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain.
I Esteban, M Vilaró, E Adrover, A Angulo, E Carrasco, N Gadea, A Sánchez, T Ocaña, G Llort, R Jover,[...]. Psychooncology 2018
17
33

Known unknowns: building an ethics of uncertainty into genomic medicine.
Ainsley J Newson, Samantha J Leonard, Alison Hall, Clara L Gaff. BMC Med Genomics 2016
46
33

Patient experience of uncertainty in cancer genomics: a systematic review.
Nicci Bartley, Christine Napier, Megan Best, Phyllis Butow. Genet Med 2020
7
57

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.
Marilyn M Li, Michael Datto, Eric J Duncavage, Shashikant Kulkarni, Neal I Lindeman, Somak Roy, Apostolia M Tsimberidou, Cindy L Vnencak-Jones, Daynna J Wolff, Anas Younes,[...]. J Mol Diagn 2017
590
25


Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare Settings.
Kathleen R Blazer, Bita Nehoray, Ilana Solomon, Mariana Niell-Swiller, Julie O Culver, Gwen C Uman, Jeffrey N Weitzel. Genet Test Mol Biomarkers 2015
35
25

Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?
Susan M Domchek, Angela Bradbury, Judy E Garber, Kenneth Offit, Mark E Robson. J Clin Oncol 2013
156
25

Physicians' attitudes about communicating and managing scientific uncertainty differ by perceived ambiguity aversion of their patients.
David B Portnoy, Paul K J Han, Rebecca A Ferrer, William M P Klein, Steven B Clauser. Health Expect 2013
42
25

The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life.
Joël Vos, Wilma Otten, Christi van Asperen, Anna Jansen, Fred Menko, Aad Tibben. Psychooncology 2008
82
25

Factors influencing the decision to share cancer genetic results among family members: An in-depth interview study of women in an Asian setting.
Shao-Tzu Li, Shirley Sun, Désirée Lie, Marie Met-Domestici, Eliza Courtney, Sapna Menon, Geok Hoon Lim, Joanne Ngeow. Psychooncology 2018
16
25

Patient re-contact after revision of genomic test results: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).
Karen L David, Robert G Best, Leslie Manace Brenman, Lynn Bush, Joshua L Deignan, David Flannery, Jodi D Hoffman, Ingrid Holm, David T Miller, James O'Leary,[...]. Genet Med 2019
46
25

Uncertainty in illness.
M H Mishel. Image J Nurs Sch 1988
571
25

Varieties of uncertainty in health care: a conceptual taxonomy.
Paul K J Han, William M P Klein, Neeraj K Arora. Med Decis Making 2011
203
16

Uncertainty in consultations about genetic testing for cancer: an explorative observational study.
Niki M Medendorp, Marij A Hillen, Laxsini Murugesu, Cora M Aalfs, Anne M Stiggelbout, Ellen M A Smets. Patient Educ Couns 2018
6
33

The language of uncertainty in genetic risk communication: framing and verbal versus numerical information.
M Welkenhuysen, G Evers-Kiebooms, G d'Ydewalle. Patient Educ Couns 2001
28
16

Gene panel testing for inherited cancer risk.
Michael J Hall, Andrea D Forman, Robert Pilarski, Georgia Wiesner, Veda N Giri. J Natl Compr Canc Netw 2014
79
16

A new definition of Genetic Counseling: National Society of Genetic Counselors' Task Force report.
Robert Resta, Barbara Bowles Biesecker, Robin L Bennett, Sandra Blum, Susan Estabrooks Hahn, Michelle N Strecker, Janet L Williams. J Genet Couns 2006
375
16

Studying medical communication with video vignettes: a randomized study on how variations in video-vignette introduction format and camera focus influence analogue patients' engagement.
Leonie N C Visser, Nadine Bol, Marij A Hillen, Mathilde G E Verdam, Hanneke C J M de Haes, Julia C M van Weert, Ellen M A Smets. BMC Med Res Methodol 2018
5
40

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
Sharon E Plon, Diana M Eccles, Douglas Easton, William D Foulkes, Maurizio Genuardi, Marc S Greenblatt, Frans B L Hogervorst, Nicoline Hoogerbrugge, Amanda B Spurdle, Sean V Tavtigian. Hum Mutat 2008
560
16

Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.
Judith Balmaña, Laura Digiovanni, Pragna Gaddam, Michael F Walsh, Vijai Joseph, Zsofia K Stadler, Katherine L Nathanson, Judy E Garber, Fergus J Couch, Kenneth Offit,[...]. J Clin Oncol 2016
101
16


Next-generation DNA sequencing.
Jay Shendure, Hanlee Ji. Nat Biotechnol 2008
16

What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer.
Sandra van Dijk, Wilma Otten, Daniëlle R M Timmermans, Christi J van Asperen, Hanne Meijers-Heijboer, Aad Tibben, Martijn H Breuning, Job Kievit. Genet Med 2005
43
16

Decision making with uncertain information: learning from women in a high risk breast cancer clinic.
Caren J Frost, Vickie Venne, Dianne Cunningham, Ruth Gerritsen-McKane. J Genet Couns 2004
33
16

Is it good to express uncertainty to a patient? Correlates and consequences for medical students in a standardized patient visit.
Danielle C Blanch, Judith A Hall, Debra L Roter, Richard M Frankel. Patient Educ Couns 2009
30
16

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
146
16

Physician expressions of uncertainty during patient encounters.
G H Gordon, S K Joos, J Byrne. Patient Educ Couns 2000
93
16

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.
Suzanne C O'Neill, Christine Rini, Rachel E Goldsmith, Heiddis Valdimarsdottir, Lawrence H Cohen, Marc D Schwartz. Psychooncology 2009
71
16

Rayyan-a web and mobile app for systematic reviews.
Mourad Ouzzani, Hossam Hammady, Zbys Fedorowicz, Ahmed Elmagarmid. Syst Rev 2016
16

Communicating the uncertainty of harms and benefits of medical interventions.
Mary C Politi, Paul K J Han, Nananda F Col. Med Decis Making 2007
191
16

No news is (not necessarily) good news: impact of preliminary results for BRCA1 mutation searches.
Alison Bish, Stephen Sutton, Christine Jacobs, Sara Levene, Amanda Ramirez, Shirley Hodgson. Genet Med 2002
31
16

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Ann Intern Med 2009
16

Strategies for managing uncertainty and complexity.
M G Hewson, P J Kindy, J Van Kirk, V A Gennis, R P Day. J Gen Intern Med 1996
75
16

Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.
Marc D Schwartz, Beth N Peshkin, Chanita Hughes, David Main, Claudine Isaacs, Caryn Lerman. J Clin Oncol 2002
175
16

Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.
J O Culver, C D Brinkerhoff, J Clague, K Yang, K E Singh, S R Sand, J N Weitzel. Clin Genet 2013
57
16

Tolerance of uncertainty: A systematic review of health and healthcare-related outcomes.
Tania D Strout, Marij Hillen, Caitlin Gutheil, Eric Anderson, Rebecca Hutchinson, Hannah Ward, Hannah Kay, Gregory J Mills, Paul K J Han. Patient Educ Couns 2018
46
16

Personalised cancer medicine.
Sarah E Jackson, John D Chester. Int J Cancer 2015
145
16

The integration of next-generation sequencing panels in the clinical cancer genetics practice: an institutional experience.
Caitlin B Mauer, Sara M Pirzadeh-Miller, Linda D Robinson, David M Euhus. Genet Med 2014
52
16

How Far Do We Go With Genetic Evaluation? Gene, Panel, and Tumor Testing.
Filipa Lynce, Claudine Isaacs. Am Soc Clin Oncol Educ Book 2016
29
16

"Possibly positive or certainly uncertain?": participants' responses to uncertain diagnostic results from exome sequencing.
Debra Skinner, Myra I Roche, Karen E Weck, Kelly A Raspberry, A Katherine M Foreman, Natasha T Strande, Jonathan S Berg, James P Evans, Gail E Henderson. Genet Med 2018
16
16

Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing.
Angela R Bradbury, Linda J Patrick-Miller, Brian L Egleston, Laura DiGiovanni, Jamie Brower, Diana Harris, Evelyn M Stevens, Kara N Maxwell, Abha Kulkarni, Tyler Chavez,[...]. Genet Med 2016
43
16


A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.
David Cella, Chanita Hughes, Amy Peterman, Chih-Hung Chang, Beth N Peshkin, Marc D Schwartz, Lari Wenzel, Amy Lemke, Alfred C Marcus, Caryn Lerman. Health Psychol 2002
170
16

Patient autonomy and the challenge of clinical uncertainty.
Mark Parascandola, Jennifer Hawkins, Marion Danis. Kennedy Inst Ethics J 2002
69
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.